Minister of Health and Community Protection Abdul Rahman bin Mohammed Al Owais issued a ministerial decree on the reduction of the price of 410 similar drugs, in line with the government's directions to reduce the prices of services, and based on the ministry's keenness to support and provide medicines at competitive prices and compatible with the lowest Gulf price in support of patients.
The list of similar drug varieties included in the reduction, a wide range of areas for the treatment of a number of diseases related to cardiovascular, high blood pressure, fat reduction and angina drugs, which are common chronic diseases in the region, and a reduction of 2 to 77%, of which 183 varieties Locally manufactured and 227 regionally globally.
The Ministry of Health and Community Protection applies the highest standards and practices in the pricing system, where the pricing system in place is subject to several influential factors, based on periodic follow-up and guidance on similar prices in the global and regional pharmaceutical markets, taking into account the patient's interest in the first place to provide sustainability in pharmaceutical brands, especially Those concerned with chronic diseases, taking into account the economics of companies operating in the State to ensure the continuity of its business and logistics operations in the State, which contributes to achieve a balanced drug market.